June 19, 2026 Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
June 19, 2026 Bielik.io Partners with BitGo Europe GmbH to Support Regulated Crypto Trading Across the EEA
